retatrutide trial phase Shows 28% Weight Loss in 80 Weeks retatrutide weight loss phase 2

Both medications work through the incretin system to lower blood glucose, but NICE guidance explicitly advises against combining them

OCA downregulates hepatic glucose and lipid metabolism by downregulating SREPB-1c and reducing endogenous bile acid production, via upregulation of FGF19 which then inhibits CYP7A1, the rate-limiting enzyme for the conversion of cholesterol to bile acids.81In addition to these primary metabolic effects, OCA may also decrease portal pressure by increasing iNOS and displaying a wider range of anti-inflammatory and antifibrotic activity.[82], [83] The FXR Ligand Obeticholic Acid in NASH Treatment (FLINT) trial was a randomised, placebo-controlled, phase IIb trial to evaluate the safety and efficacy of OCA in NASH

4th, Khalil, S

Focus on consistency, not speed, and trust the process your body is working through in these first 30 days on a GLP-1